Bristol Myers Squibb antibody candidate for Alzheimer's granted Fast Track status
Source: SeekingAlpha
2025-10-01 17:17:39 ET
More on Bristol-Myers Squibb Company
- Bristol-Myers Squibb Company (BMY) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum Transcript
- Bristol Myers Squibb: Buy This Deep Bargain Before The Market Wakes To Income
- Bristol-Myers Squibb Company (BMY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
- Trump holding off on pharma tariffs to negotiate more deals - report
- FDA won't accept new drug applications during government shutdown
Read the full article on Seeking Alpha
For further details see:
Bristol Myers Squibb antibody candidate for Alzheimer's granted Fast Track status
Bristol-Myers Squibb Company
NASDAQ: BMY
BMY Trading
0.33% G/L:
$59.135 Last:
3,589,652 Volume:
$59.67 Open:
BMY Latest News
March 09, 2026 06:59:00 am
Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma
BMY Stock Data
$123,325,918,376
2,034,328,000
N/A
1394
N/A
Pharmaceuticals
Healthcare
US
Princeton
